Statement: Grain Growers of Canada pleased that CP rail back on track

May 30, 2018

“Canadian grain farmers are delighted that talks between CP Rail and both Unions have resulted in agreements. The announcement today that the 3000 members of the Teamsters union will be back at work tomorrow, ending a work stoppage less than 24 hours old is good news for Canadian shippers. With grain bins and elevators still full across the Prairies we are counting on both railways to work to full capacity to get our backlogged grain to export position.

“We would like to thank the Prime Minister and Minister Hajdu for their leadership in encouraging the two sides to reach the negotiated outcome that ended the work stoppage. With this positive news, and the recent passage of Bill C-49, grain farmers are excited about the opportunity that exists to have a rail transportation system that works for hard working farm families and the rural communities they live in.”

– Jeff Nielsen, President, Grain Growers of Canada

Source : Grain Growers of Canada

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.